No Data
No Data
Barclays Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $263
Barclays analyst Stephanie Davis maintains $Cencora(COR.US)$ with a buy rating, and maintains the target price at $263.According to TipRanks data, the analyst has a success rate of 41.0% and a total a
Analysts Are Bullish on Top Healthcare Stocks: Teva Pharmaceutical (TEVA), Cencora (COR)
Wells Fargo Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $236
Wells Fargo analyst Steve Baxter maintains $Cencora(COR.US)$ with a hold rating, and adjusts the target price from $235 to $236.According to TipRanks data, the analyst has a success rate of 56.6% and
Insider Sale: Cencora Inc (COR) CEO Steven Collis Sells 10,755 Shares
Analysts' Top Healthcare Picks: Inspire Medical Systems (INSP), Cencora (COR)
Walgreens Further Cuts Stake in Drug Distributor Cencora
No Data